Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 521 | 472 | 534 | 533 | 609 |
| Operating Income | -521 | -472 | -534 | -533 | -609 |
| Interest Expense | 836 | 387 | 193 | 134 | 69 |
| Other Income | 16 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,341 | -859 | -727 | -666 | -678 |
| Net Income Continuous | -1,341 | -859 | -727 | -666 | -678 |
| Net Income | $-1,341 | $-859 | $-727 | $-666 | $-678 |
| EPS Basic Total Ops | -1.39 | -0.73 | -0.80 | -0.80 | -0.80 |
| EPS Basic Continuous Ops | -1.39 | -0.91 | -0.78 | -0.71 | -0.73 |
| EPS Diluted Total Ops | -1.39 | -0.73 | -0.80 | -0.80 | -0.80 |
| EPS Diluted Continuous Ops | -1.39 | -0.91 | -0.78 | -0.71 | -0.73 |
| EBITDA(a) | $273 | $-132 | $-383 | $-422 | $-554 |